Comparison of twice-daily biphasic insulin aspart 70/30 (BIAsp 70/30) with once-daily insulin glargine (GLA) in patients with type 2 DM on oral antidiabetic agents

被引：0
|
作者：
Raskin, P
Rojas, P
Allen, E
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A143 / A143
页数：1
相关论文
共 50 条
  • [31] Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US
    Ray, J. A.
    Valentine, W. J.
    Roze, S.
    Nicklasson, L.
    Cobden, D.
    Raskin, P.
    Garber, A.
    Palmer, A. J.
    DIABETES OBESITY & METABOLISM, 2007, 9 (01): : 103 - 113
  • [32] Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery
    Yeldandi, Renuka R.
    Lurie, Alexander
    Baldwin, David
    DIABETES TECHNOLOGY & THERAPEUTICS, 2006, 8 (06) : 609 - 616
  • [33] Comparison of a twice daily injection of insulin aspart 50 with insulin aspart 30 in patients with poorly controlled type 2 diabetes
    Shi, Chunhong
    Sun, Luyan
    Bai, Ran
    Wang, Hao
    Liu, Dan
    Du, Jianling
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (06) : 1091 - 1096
  • [34] Optimising glycaemic control with BIAsp30 (once or twice daily) in combination with oral antidiabetic agents in type 2 diabetes
    Suwanwalaikorn, S
    DIABETOLOGIA, 2005, 48 : A308 - A308
  • [35] Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial
    Onishi, Yukiko
    Yamada, Kenichi
    Zacho, Jeppe
    Ekelund, Jan
    Iwamoto, Yasuhiko
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (02) : 210 - 217
  • [36] Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients
    Boehm, BO
    Home, PD
    Behrendt, C
    Kampt, NM
    Lindholm, A
    DIABETIC MEDICINE, 2002, 19 (05) : 393 - 399
  • [37] A Thrice Daily Regimen with Biphasic Insulin Aspart 50 Is More Effective and as Safe as Twice Daily Biphasic Insulin Aspart 30 in Chinese Subjects with Type 2 Diabetes
    Gao, Yan
    DIABETES, 2010, 59 : A153 - A153
  • [38] CLINICAL AND COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 ONCE OR TWICE DAILY VERSUS INSULIN GLARGINE IN TYPE 2 DIABETES MELLITUS: A MODELING ANALYSIS IN THE CHINESE SETTING
    Palmer, J. L.
    Beaudet, A.
    White, J.
    Plun-Favreau, J.
    Smith-Palmer, J.
    VALUE IN HEALTH, 2010, 13 (07) : A528 - A528
  • [39] Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naive subjects with type 2 diabetes
    Yang, Wenying
    Xu, Xiangjin
    Liu, Xiaomin
    Yang, Gangyi
    Seino, Yutaka
    Andersen, Henning
    Jinnouchi, Hideaki
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (12) : 1599 - 1608
  • [40] Efficacy and safety comparison of once daily basal insulin and twice daily premixed insulin in combination with oral antidiabetic agents (OAD) in type 2 diabetes (T2DM)
    Yang, Wenying
    Bu, Shi
    Guo, Xiaohui
    Lu, Guizhi
    Yang, Zhao-Jun
    Ren, Tingting
    Gao, Yan
    DIABETES, 2007, 56 : A554 - A554
12345